Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Niina Paunu"'
Autor:
Riikka Nurminen, Ebrahim Afyounian, Niina Paunu, Riku Katainen, Mari Isomäki, Anssi Nurminen, Mauro Scaravilli, Jenni Tolppanen, Vidal Fey, Anni Kivinen, Pauli Helén, Niko Välimäki, Juha Kesseli, Lauri A. Aaltonen, Hannu Haapasalo, Matti Nykter, Kirsi J. Rautajoki
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Predisposing factors underlying familial aggregation of non-syndromic gliomas are still to be uncovered. Whole-exome sequencing was performed in four Finnish families with brain tumors to identify rare predisposing variants. A total of 417 d
Externí odkaz:
https://doaj.org/article/3f05e1aae8db4dccab392f0bae132f55
Autor:
Veera V. Salminen, Eila Lantto, Tuija Poussa, Raija Kallio, Maija Lavonius, Raija Ristamäki, Markus J. Mäkinen, Eija Pääkkö, Jari Sundström, Eetu Heervä, Sirpa Leppä, Johanna Mattson, Ari Ristimäki, P.J. Osterlund, Arno Nordin, Eija Sutinen, Eija Korkeila, T. Salminen, Kaisa Lehtomäki, Aki Uutela, P. Ryymin, Irina Rinta-Kiikka, Riikka Huuhtanen, Ali Ovissi, Olli Carpén, Marjut Timonen, Jani Saunavaara, Nina Lundbom, Heikki Mäkisalo, A.I. Hakkarainen, P. Halonen, Eveliina Lammentausta, Annika Ålgars, Helena Isoniemi, Johanna Virtanen, L. M. Soveri, R. Blanco Sequeiros, Nieminen Lasse, Niina Paunu, Heidi Penttinen, E. Liukkonen, Petri Bono, Siru Mäkelä, Martine Vornanen, Emerik Osterlund, Juhani Kosunen
Publikováno v:
ESMO Open
Background Colorectal cancer liver metastases respond to chemotherapy and targeted agents not only by shrinking, but also by morphologic and metabolic changes. The aim of this study was to evaluate the value of advanced magnetic resonance imaging (MR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9ddcc105fe6b21373dbe71abb69349
http://urn.fi/urn:nbn:fi-fe2022030221470
http://urn.fi/urn:nbn:fi-fe2022030221470
Autor:
Riikka-Liisa Vuorinen, Timo Purmonen, Harri Sintonen, Niina Paunu, Taina Reunamo, Taina Turpeenniemi-Hujanen, Pirkko-Liisa Kellokumpu-Lehtinen, Vesa Kataja, Antti Jekunen
Publikováno v:
Anticancer research. 39(10)
Background/aim Tyrosine kinase inhibitors are important in the treatment of metastatic renal cell cancer (mRCC). The aim of the study was to evaluate the costs and effects of sunitinib in mRCC. Patients and methods A total of 81 mRCC patients who rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab1143fd911d4f86b8347bb9868daad5
https://pubmed.ncbi.nlm.nih.gov/31570450
https://pubmed.ncbi.nlm.nih.gov/31570450
Autor:
P-L Kellokumpu-Lehtinen, Veera V. Salminen, Tiina Luukkaala, Pia Österlund, E. Osterlund, Niina Paunu, Petri Bono, Helena Isoniemi, P. Nyandoto, T. Salminen, Leena-Maija Soveri, Kaisa Lehtomäki, R. Huuhtanen, P. Halonen
Publikováno v:
Annals of Oncology. 31:S223
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::727e17d20e1c6a1034cfb3222167200b
https://doi.org/10.1016/j.annonc.2020.04.033
https://doi.org/10.1016/j.annonc.2020.04.033
Publikováno v:
Journal of palliative medicine. 21(6)
The optimal treatment of malignant ascites (MA) and feasibility of the management with free drainage remain unclear.To study the success of drainage, complications, and survival after paracentesis or insertion of an indwelling tunneled catheter (TC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fac7712340913faaaa1bfd5068c250a
https://pubmed.ncbi.nlm.nih.gov/29489450
https://pubmed.ncbi.nlm.nih.gov/29489450
Autor:
Jorma Isola, Niina Paunu, Pauli Helén, Pekka Laippala, Heikki Helin, Eero Pukkala, Risto Sankila, Helena Miettinen, Hannu Haapasalo, Kalle O.J. Simola
Publikováno v:
International Journal of Cancer. 97:819-822
Twenty-four Finnish families with 2 or more glioma patients were identified through questionnaires sent to 369 consecutive glioma patients receiving surgery at Tampere University Hospital during 1983–94. To explore whether unusual cancer susceptibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a026c3342d7207ec309069d7d8762041
https://doi.org/10.1002/ijc.10107
https://doi.org/10.1002/ijc.10107
Autor:
Helena Miettinen, Heikki Helin, Leo Paljärvi, Hannu Kalimo, Hannu Haapasalo, Immo Rantala, Niina Paunu
Publikováno v:
Journal of Neuro-Oncology. 55:29-37
Using the novel tissue microarray technique, we studied immunohistochemical expression of cell cycle regulators p53, p21, pRb in 42 grade II oligodendrogliomas, 16 grade III anaplastic oligodendrogliomas, 10 primary and 4 recidive grade II oligoastro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34690328e6e89b8fd0da7888b9969add
https://doi.org/10.1023/a:1012961918848
https://doi.org/10.1023/a:1012961918848
Autor:
Jorma Isola, Kirsi Syrjäkoski, Risto Sankila, Pauli Helén, Mika P. Matikainen, Kalle O.J. Simola, Mika Niemelä, Niina Paunu, Hannu Haapasalo
Publikováno v:
Journal of Neuro-Oncology. 55:159-165
The high incidence of gliomas in Li–Fraumeni families and the high frequency of somatic p53 mutations in sporadic glial tumors have raised the possibility that germline p53 mutations could play an important role in familial aggregation of gliomas.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e160d0294391af03d78af479bcf5d999
https://doi.org/10.1023/a:1013890022041
https://doi.org/10.1023/a:1013890022041
Autor:
Niina Paunu, Ritva Karhu, Helena Miettinen, Juha Kononen, Pauli Sallinen, Hannu Haapasalo, Pauli Helén, Satu-Leena Sallinen, Kalle O.J. Simola, Pekka Laippala
Publikováno v:
Genes, Chromosomes and Cancer. 29:339-346
Familial occurrence of gliomas, in the absence of well-defined hereditary multisystem disorders, is reported occasionally. We describe 17 families that have been afflicted with two or more gliomas but do not raise suspicion of other inheritable syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::570c92e55897100b481e6e9d61707222
https://doi.org/10.1002/1098-2264(2000)9999:9999<::aid-gcc1049>3.0.co
https://doi.org/10.1002/1098-2264(2000)9999:9999<::aid-gcc1049>3.0.co
Autor:
Aija, Knuuttila, Annamari, Rouhos, Eeva-Maija, Karjalainen, Henrik, Riska, Matti, Pietiläinen, Niina, Paunu, Eija-Riitta, Salomaa
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 125(4)
Treatment of advanced or metastatic non-small cell lung cancer with current cytotoxic agents is at its best able to only slow down the progression of the disease, while no curative treatment is known. Novel antiangiogenetic agents such as Bevacizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::318f29a4a4efe9b4ae58dae385da27e8
https://pubmed.ncbi.nlm.nih.gov/19358416
https://pubmed.ncbi.nlm.nih.gov/19358416